Medical

U.K. resident Fiona McNiven can tell you how chronic pain can wear a person down, as she spent more than three decades battling muscle and neuropathic pain.

Researchers at Johns Hopkins University and the University of Maryland School of Pharmacy have developed a set of novel, first-in-class drugs that inhibit hypoxia-inducible factors 1 and 2, a pair of transcription factors considered to be "master regulators" of cancer progression.

Chronic breathlessness affects every part of a person's life—including their sex life, with people experiencing breathlessness saying they have greatly reduced satisfaction with their overall sexual life. Flinders University researchers have found from a national survey that the often-underplayed co...

Imagine being able to assess how healthy the front of our eyes are not only in hospitals, but also in remote eye-screening camps, elderly-care facilities, pharmacies, or even train stations. That is the future a research team led by Professor Toru Nakazawa at the Graduate School of Medicine, Tohoku ...

Redefining obesity based not only on body mass index (BMI) but on whether excess body fat is causing measurable health problems may complicate diagnosis and delay treatment, according to an Endocrine Society guideline communication published in The Journal of Clinical Endocrinology & Metabolism.

The FDA has often failed to share information on how it determines whether advisory committee members have financial conflicts of interest, according to a new review.

Eli Lilly’s obesity pill was approved by the FDA, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill.

The FDA is moving toward allowing compounding pharmacies to produce injectable peptides that were banned over significant safety concerns

Positive safety profile of novel drug compound is surprise for class of synthetic opioids shelved years ago.

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter.